Home Frequently Asked Questions

Frequently Asked Questions FAQ

Explore answers to common questions about BOMRA services.

How do I register

You would need to submit a dossier / application to BoMRA, upon payment of the requisite application fee, and the dossier / application will be evaluated by the Department of Product Evaluation and Registration (DPER) to determine product compliance with established criteria of quality, safety, and efficacy.

You are required to submit a service request form either via email or submission on the integrated information management system, BRIMS. To access the service request form, click here. You shall be issued with a proforma invoice or sales order which you will use to process /make a payment for the intended service. After payment, you can submit the proof of payment, and the application to BoMRA. For more details visit the following guidelines:

  1. Guideline on submission of applications and BoMRA timelines
  2. Guideline for submission of requests for paid services

These can be accessed on the BoMRA website. You can access them at the following link

The guidelines and application forms are available on BoMRA website www.bomra.co.bw.

What is the Department of Product Evaluation and Registration (DPER)?

DPER is responsible for evaluating, registering, and monitoring human medicines, veterinary medicines, medical devices, and cosmetics in Botswana, ensuring they meet safety, efficacy, and quality standards.

To register a product, you must submit a comprehensive dossier containing detailed information on the product’s safety, efficacy, and quality. The dossier will undergo a scientific assessment before approval.

The registration process can take several months, depending on the complexity of the product and the completeness of the submitted documentation.

After approval, your product will be granted Marketing Authorization (MA) and added to the national register, allowing you to market or distribute the product in Botswana.

Marketing Authorization is typically valid for 5 years. After this period, a renewal application must be submitted to maintain the product’s registration.

Yes, you may apply for an exemption for essential unregistered medical products, particularly those urgently needed for public health. Each request will be evaluated based on the product’s necessity and benefit.

A variation refers to changes in an already registered product (such as modifications to packaging, formulation, or manufacturing process). A renewal involves reauthorizing a product after the original Marketing Authorization expires.

Veterinary medicines undergo a similar evaluation process as human medicines. A dossier containing data on safety, efficacy, and quality must be submitted for review and approval.

Yes, cosmetic products are regulated by DPER. While cosmetics do not require full registration, they must undergo a notification process to ensure compliance with safety standards.

If your product does not meet the required standards, it will not be granted Marketing Authorization. You will receive feedback outlining the issues, and you may address them before resubmitting.

What is the role of the Department of Licensing and Enforcement (DLE)?

The DLE is responsible for overseeing the control of imports, exports, and transit of all regulated products. The department also inspects and licenses premises across the supply chain to ensure compliance with regulatory standards and conducts testing to verify product quality.

The DLE ensures safety by inspecting and licensing premises, testing products for compliance with established specifications, and identifying substandard or falsified products before they enter the market.

Premises involved in the storage, distribution, or sale of regulated products must apply the DLE. The application will be assessed, and a site inspection will be conducted to ensure compliance with regulatory requirements.

To import or export regulated products, businesses must meet DLE’s documentation, registration, and inspection requirements. All products must comply with safety and regulatory standards before they can be cleared for trade.

If a product fails testing or is found to be substandard, the DLE will take necessary enforcement actions, such as product recall, suspension of licenses, or legal penalties, to protect public health and safety.

The MRSA is the legislation that governs the regulation of medicines, medical devices, and related products in Botswana. The DLE enforces the provisions of this Act to ensure that only safe, effective, and high-quality products are available in the market.

Exemption requests may be considered on a case-by-case basis for specific circumstances, such as urgent medical needs. The DLE evaluates each request based on the product’s safety and public health benefits.

Non-compliance with regulatory standards may result in fines, suspension or revocation of licenses, or legal action, depending on the severity of the violation. The DLE enforces the MRSA to ensure compliance and safeguard public health.

Inspections are carried out regularly and as needed, based on the type of premises and the products handled. This ensures that all regulated entities remain compliant with safety and quality standards.

Suspicious or non-compliant products can be reported directly to the DLE through official channels, such as online forms, phone, or email. The department investigates all reports to ensure product safety and compliance.

How do I get my veterinary medicine registered/approved?

You need to submit a dossier / application to BoMRA, upon payment of the relevant fee, and the dossier will be evaluated by the DPER – Veterinary Unit to determine the suitability (quality, safety, and efficacy) of the product.

The requirements for registration of veterinary medicines have been shared on BoMRA website www.bomra.co.bw. You can access the relevant guidelines on this link

The requirements for registration of complementary veterinary medicines, are different from the guidelines for Pharmaceutical and Immunological veterinary products mentioned above. A specific guideline for registration of complementary veterinary medicines is also available on the website..

You are required to submit a service request form either via email or submission on the integrated information management system, BRIMS. To access the service request form, click here. You shall be issued with a proforma invoice or sales order which you will use to process /make a payment for the intended service. After payment, you can submit the proof of payment, and the application to BoMRA. For more details visit the following guidelines:
a. Guideline on submission of applications and BoMRA timelines
b. Guideline for submission of requests for paid services
These can be accessed on the BoMRA website. You can access them at the following link

The dossiers for registration of pharmaceutical and immunological veterinary medicines should be in CTD format. These should be submitted as an electronic text-selectable PDF and/or Word Format. However, the dossiers for registration of complementary veterinary medicines shall not be in CTD format. The dossiers shall be compiled in accordance with the current, specific guideline for registration of complementary veterinary medicines, which is available on the website.

BoMRA utilises different assessment pathways depending on:
1. the choice of the applicant, and
2. availability of evidence of registration of the VMPs in other jurisdictions that BoMRA recognises in line with the Recognition/Reliance Policy and procedures.
Acknowledging the general principles of FIFO, and unless in the case of a declared animal / public health emergency,
a. if a product is registered, in a country recognised by BoMRA, an abbreviated assessment pathway shall be employed. With this pathway, a regulatory decision shall be made within 6 to 12 months from date of submission.
b. in cases where the applicant chose an expedited assessment pathway, a regulatory decision shall be made within 12 months from date of submission.
c. if it is a locally (partially/fully) manufactured VMP, where there is no evidence of registration from a recognised jurisdiction, a regulatory decision shall be made within 18 months from date of submission.
d. if it is a fully foreign manufactured VMP, where there is no evidence of registration from a recognised jurisdiction, a regulatory decision shall be made within 24 months from date of submission.
NB. This timeline is subject to review

You can send an email to the Veterinary Medicines Unit on  registration.vetmeds@bomra.co.bw, stating exactly what you would like to know about the product, quoting the unique reference number assigned by BoMRA. After the commissioning of the integrated regulatory information management system, applicants shall be able to access their accounts, and track or verify the status of their applications online, on the self-service portal.

The applicable fees for registration of veterinary medicines are available on the website. You can access the fees here.

Regulation of Dips is currently done by the Registrar of Agrochemicals, in the Department of Crop Production, Ministry of Agriculture. A process of engagement has been initiated to determine if the regulation of dips should remain with the Ministry of Agriculture or be moved to BoMRA. Any new developments shall be communicated by way of a Notice to all Stakeholders.

BoMRA publishes the register of approved veterinary medicinal products on its website www.bomra.co.bw

The Authority has developed a process for exemption of medicines from registration in accordance with the provision of the MRSA section 23 (3). Refer to the guideline for exemption from registration of VMPs available on the website for more detailed process and requirements.

Yes, provided there are no exclusive distributorship rights declared.

Any medicinal product that is intended for use in or on an animal for the purposes of treatment, prevention, alleviating or diagnosis of a disease, clinical condition or infection by any pathogen should be registered by the Authority in Botswana. If the manufacturer, and / or potential applicant is not aware of the correct classification of their products in terms of the appropriate regulatory path to follow, there is a registrability process that the Authority, has developed. The Guideline and Registrability Application Forms are available on the website.

Yes, there are certain active substances that are prohibited for use in food producing animals. The reasons include the need to promote prudent AMU and management of AMR among other things. For specific details of the molecules of concern, refer to the Stautory Instrument 76 of 2020 and Statutory Instrument 103 of 1987.

No, currently there is no list of critical or essential medicines list for veterinary medicinal products

Currently the Veterinary Medicines ZAZIBONA has made a deliberate decision to invite expression of interests to submit applications for only pharmaceutical (small molecule) formulations, as a pilot project. These were submitted, and the selection was done. However, arrangements are underway to enable submission and assessment of the selected products. Any new developments related to the progress of this process shall be communicated in due course.

Botswana Medicines Regulatory Authority
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.